PodParley PodParley
PodParley
Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage episode artwork

EPISODE · Nov 14, 2022 · 45 MIN

Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage

from Project Medtech · host Project Medtech

In this episode, Alison Burklund, Kate Rumrill and Duane Mancini discuss their Medtech companies, comparing and contrasting raising money at a series D vs. series A, culture at a series A vs series D, coming into the CEO role vs. being a co-founder, and so much more. Alison Burklund LinkedIn Nanopath Website Kate Rumrill LinkedIn Ablative Solutions Website Project Medtech Website Duane Mancini LinkedIn Project Medtech LinkedIn

Episode metadata supplied by the publisher feed · Published Nov 14, 2022

Embed this episode

NOW PLAYING

Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage

0:00 45:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 45 minutes long.

When was this Project Medtech episode published?

This episode was published on November 14, 2022.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!